2013
DOI: 10.1155/2013/302131
|View full text |Cite
|
Sign up to set email alerts
|

Curative Effects of ZHENG-Based Fuzheng-Huayu Tablet on Hepatitis B Caused Cirrhosis Related to CYP1A2 Genetic Polymorphism

Abstract: Aim. To investigate the correlation of Fuzheng-Huayu tablet (FZHY) efficacy on chronic hepatitis B caused cirrhosis (HBC) and single nucleotide polymorphisms (SNPs) of CYP1A2. Methods. After 111 cases of HBC with 69 excess, 21 deficiency-excess, and 21 deficiency ZHENGs (ZHENG, also called traditional Chinese medicine syndrome) were treated by FZHY for 6 months, clinical symptoms, Child-Pugh score, and ZHENG score were observed. Three of the SNPs in CYP1A2 gene were detected and analyzed using SNaPshot assay. … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2014
2014
2021
2021

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(4 citation statements)
references
References 22 publications
0
4
0
Order By: Relevance
“…b) TCM syndrome identification methods based on omics technologies [13], including proteomic, transcriptomic, metabolomic and bioinformatic analysis in hepatitis B and hepatitis B-caused cirrhosis [14][15][16][17], and dynamic network biomarkers in chronic hepatitis B [18]. c) Efficacy evaluation methods of TCM individualization treatment based on molecular classification of "Disease-Syndrome" in hepatitis B-caused cirrhosis [16].…”
Section: "Integration" Approach Based On the Integration Of Reduction...mentioning
confidence: 99%
See 1 more Smart Citation
“…b) TCM syndrome identification methods based on omics technologies [13], including proteomic, transcriptomic, metabolomic and bioinformatic analysis in hepatitis B and hepatitis B-caused cirrhosis [14][15][16][17], and dynamic network biomarkers in chronic hepatitis B [18]. c) Efficacy evaluation methods of TCM individualization treatment based on molecular classification of "Disease-Syndrome" in hepatitis B-caused cirrhosis [16].…”
Section: "Integration" Approach Based On the Integration Of Reduction...mentioning
confidence: 99%
“…d) Evaluation methods of clinical TCM syndrome pharmacology in hepatitis B-caused cirrhosis based on genomic [16], transcriptomic [17] and metabolomic analysis [18].…”
Section: "Integration" Approach Based On the Integration Of Reduction...mentioning
confidence: 99%
“…This needs further study on the relationships between genetic variation or mutation and efficacy and safety of TCM treatment. Based on genotyping technologies of pharmacological genomics, previous study has that CYP1A2-G2964A is related to the curative effect of Fuzheng-Huayu tablet, a formula, which is able to improve the clinical symptoms of patients with the deficiency syndrome in hepatitis B caused cirrhosis [6]. Studies on transcriptional profiling and miRNA target network analysis have evidenced the efficacy of Fuzheng-Huayu [7].…”
Section: Accurate Tcm Treatmentmentioning
confidence: 99%
“…FZHY tablet exhibits antifibrotic activity by inducing apoptosis in HSC-T6 cells through p38 and SAPK/JNK pathways [ 99 , 104 ], and inhibits liver fibrosis through decreasing transcription of TIMP-1, PDGF-B, and PDGF receptor β1 in vivo [ 99 ]. A study of chronic HBV infection-induced fibrosis and cirrhosis patients showed that its therapeutic efficacy is closely related to the GA plus AA polymorphism of CYP 1 A 2 [ 105 ].…”
Section: Potent Natural Products and Herbal Medicines For The Managemmentioning
confidence: 99%